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ABSTRACT: Accurate mapping of small changes in pH is
essential to the diagnosis of diseases such as cancer. The difficulty
in mapping pH accurately in vivo resides in the need for the
probe to have a ratiometric response so as to be able to
independently determine the concentration of the probe in the
body independently from its response to pH. The complex FeII-
DOTAm-F12 behaves as an MRI contrast agent with dual 19F
and CEST modality. The magnitude of its CEST response is
dependent both on the concentration of the complex and on the
pH, with a significant increase in saturation transfer between pH
6.9 and 7.4, a pH range that is relevant to cancer diagnosis. The
signal-to-noise ratio of the 19F signal of the probe, on the other
hand, depends only on the concentration of the contrast agent and is independent of pH. As a result, the complex can
ratiometrically map pH and accurately distinguish between pH 6.9 and 7.4. Moreover, the iron(II) complex is stable in air at
room temperature and adopts a rare 8-coordinate geometry.
■ INTRODUCTION
The pH gradient between interstitial and intracellular cells is
known to affect cell regulatory processes as well as drug uptake
and efficiency. In cancer, for instance, poor perfusion and high
metabolic rates of tumor cells lead to their hypoxic and acidic
nature which, in turn, leads to higher production of lactate.1,2
As a result, the extracellular environment of tumors is slightly
more acidic than that of normal tissues.3,4 Although small (ca.
0.7 pH units), the ability to map this variation in vivo is
important both in terms of diagnosing, but also in predicting
the response of a cancer to certain drugs.5−7
Magnetic resonance imaging (MRI) is a preferred in vivo
imaging technique due to its high resolution and lack of
ionizing radiation.8 Accurate pH mapping by MRI, however,
requires the use of pH-responsive contrast agents. Several such
contrast agents have been reported, including Gd-based pH
sensitive relaxivity agents9−13 and chemical exchange saturation
transfer (CEST) agents.14−18 The major drawback of GdIII-
based probes is that signal intensity is proportional to both the
concentration of the contrast agent and the pH. In vivo pH
mapping thus assumes that the concentration of contrast agent
is constant throughout the tissue, a flawed assumption given the
poor perfusion of solid tumors where acidolysis occurs.19
Consequently, pH mapping with GdIII-based contrast agents
can yield ambiguous results. Approaches like simultaneously
injecting pH sensitive and insensitive contrast agents,20 such as
administering a cocktail of T1 and T2 agents,
21 19F/18F MR-
PET agents,22 or 19F/1H probes,23 have been used to overcome
these issues. However, one cannot assume that two different
probes will colocalize, hence their limited utility.
CEST probes that have two (or more) NMR-distinguishable
sets of exchangeable protons with different pH responses are
one solution to this problem.24 Since these probes are
ratiometric, the contrast observed is independent of the
concentration of the probe. Both diamagnetic and paramagnetic
CEST molecules have been reported for such applica-
tions,15,16,18,25−27 but both have drawbacks. For instance, the
mobile resonances of the diaCEST probes are too close to
those of the bulk water signal and endogenous biomolecules,
resulting in spillover effects and background overlap.15 On the
other hand, pH-responsive lanthanide-based paraCEST agents
often require high-irradiation-power pulses in order to saturate
the CEST signal. This high-irradiation power limits their
translation to animal or cell studies because it leads to high
deposition of energy in the tissue which causes heating.14,25
CEST contrast agents act by decreasing the intensity of the
bulk water signal upon selectively saturating the resonance
frequency of the mobile protons of the agent (NH, OH, or
coordinated H2O).
28 Since the exchange rate of these mobile
protons is highly pH-dependent, CEST agents are uniquely
suited for in vivo pH mapping. Given that the effectiveness of a
CEST contrast agent is determined in part by a chemical shift
difference (Δω) between water and the exchangeable 1H,
paramagnetic metal complexes that shift the exchangeable
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proton further away from the bulk water signal show improved
sensitivity. Although a majority of such paramagnetic complexes
have focused on lanthanide ions, recent work by J. Morrow and
others have demonstrated that certain paramagnetic first row
transition metals including FeII have much potential as CEST
agents.29−38 This class of compounds can also behave as pH
probes. Indeed, the transition-metal-based CEST agents
reported so far in the literature do show a pH-dependent
response, with an increase in saturation transfer effect (ST%) at
alkaline pH values.29,30,33,35,39,40
Notably, FeII also shows substantial advantages in the design
of fluorinated MRI probes. Recent work by our group has
demonstrated that fluorinated FeII complexes present much
higher sensitivity than their diamagnetic analogues, and,
remarkably, than their paramagnetic lanthanide ones.41 This
increase in sensitivity is due to the much shorter longitudinal
relaxation times, T1, of the fluorines and to a ratio of transverse
to longitudinal relaxation times, T2/T1, closer to unity.
Combining these two bodies of work, we postulated that a
macrocyclic FeII complex bearing both exchangeable protons
and fluorines, FeII-DOTAm-F12 (Figure 1), would behave as a
ratiometric pH-responsive MRI contrast agent whereby the
CEST signal would be pH-dependent, but the 19F image would
not be. This, in turn, would enable accurate pH mapping
without the use of multiple probes.
■ EXPERIMENTAL SECTION
Single Crystal X-ray Diffraction Measurements. Orange
crystals suitable for X-ray diffractions were grown over several days
by slow diffusion of hexane into the mixture of ethanol/toluene (2:1)
solution containing the iron complex.
X-ray data were collected on a Bruker-AXS Venture PHOTON-100
diffractometer at 123(2) K.42 The data collection was carried out using
Cu Kα radiation (parabolic mirrors) with a frame time of 10 s and a
detector distance of 4.0 cm. A strategy program was used to ensure
complete coverage of all unique data to a resolution of 0.80 Å. All
major sections of frames were collected with 0.80° steps in ω or ϕ at
different detector positions in 2θ. The intensity data were corrected for
absorption and decay (SADABS).43 Final cell constants were
calculated from 2798 strong reflections from the actual data collection
after integration (SAINT).43
The structure was solved using SHELXT-2014 (Sheldrick, 2014)44
and refined with SHELXL-2014 (Sheldrick, 2014).45 The space group
P21/n was determined on the basis of systematic absences and
intensity statistics. A direct-methods solution was calculated, which
provided most non-hydrogen atoms from the E-map. Full-matrix least-
squares/difference Fourier cycles were performed, which located the
remaining non-hydrogen atoms. All non-hydrogen atoms were refined
with anisotropic displacement parameters. The protons on the
nitrogen atoms were determined from the difference map and refined
with individual isotropic displacement parameters. All non-hydrogen
atoms were refined with anisotropic displacement parameters. All
hydrogen atoms were placed in ideal positions and refined as riding
atoms with relative isotropic displacement parameters. The final full-
matrix least-squares refinement converged to R1 = 0.0605 and wR2 =
0.1718 (F2, obsd data). See Tables S1, S4−S7 for detailed
crystallographic information.
FeII-DOTAm-F12 crystallized in the space group P21/n with
pseudo-C-centering. The structure has a molecular 2-fold axis that is
near the crystallographic 2-fold axis. The crystal is disordered and
contains two isomers in an approximate 0.67:0.33 ratio. Several
restraints (SAME, SADI, RIGU) were used to model the 12-member
rings and the four methylene carbon atoms between the amide groups.
There were 1268 restraints used in total. Most carbon atoms within
the two rings were paired with EADP constraints if these were within
about 0.4 Å. A putative partially occupied water was placed in a void
region. PLATON/SQUEEZE46 was used to check for potential
disordered solvent in addition to the one partial atom found. 279 Å3 of
the total 4450 Å3, or 6.3% of the unit cell, was determined to be void
space after removing the putative, partially occupied water molecule.
The total number of electrons within these voids in the unit cell was
refined to 23. This suggests that some atoms are disordered beyond
the point of resolution. The partially occupied water molecule was
retained for the final result. The hydrogen atoms of the water were not
placed but were included in the empirical formula.
The magnetic moment of FeII-DOTAm-F12 was measured both by
SQUID and by NMR according to the Evans method.
Magnetic Moment: SQUID Measurement. Temperature-
dependent magnetic susceptibility data were collected on a finely
ground powder of FeII-DOTAM-F12 in the temperature range 2−300
K at a heating rate 1 K/min with an applied magnetic field of 1 T with
a Quantum Design (MPMS-5S) SQUID magnetometer. The
accurately weighed sample was loaded into a gel capsule that was
then placed inside a plastic straw. The straw was mounted on a
transporter rod that was placed in the magnetometer. All the data were
corrected for diamagnetic contributions due to the core molecular
diamagnetism of the sample using Pascal’s constants.47
Magnetic Moment: Evans Method. The effective magnetic
moment of FeII-DOTAm-F12 in solution was determined by 1H NMR
using the Evans method at 293.7 K in D2O with 9% t-butanol as
reference standard on a Bruker 600 spectrometer at 600 MHz using a
previously published procedure.48 Importantly, the absence of free iron
in the FeII-DOTAm-F12 sample was first confirmed by a xylenol
orange test. The concentration of the FeII-DOTAm-F12 in solution
was measured by relaxometry after acid digestion and confirmed by
ICP-MS (inductively coupled plasma mass spectrometry). For the
determination of iron concentration by relaxometry, the complex was
digested with nitric acid (1:10, sample/HNO3 (v/v)) in a sealed vial at
160 °C for 24 h. Subsequently, R1 (longitudinal relaxation rate) was
measured in triplicate at 21 MHz and 25 °C using a Stelar Spinmaster
relaxometer. The sample iron concentration was then assessed with a
previously established calibration curve. The concentration of iron in
the sample solution was also determined by ICP-MS after digestion in
a microwave oven. The concentration of FeII-DOTAm-F12 was
determined to be 2.27 mM.
The sample FeII-DOTAm-F12 dissolved in D2O was placed in a
capillary tube (1 mm) that was inserted in a 5 mm NMR tube
containing only D2O and t-butanol. The NMR spectra showed two
signals for t-butanol; the signal from solution outside the capillary
serves as a diamagnetic reference while the signal from the solution in
the capillary was shifted due to the presence of paramagnetic FeII-
DOTAm-F12. The observed chemical shift difference was used to




















where Δf is the chemical shift difference in Hz of the reference
standard in the presence and absence of paramagnetic sample, f is the
operating frequency of the spectrometer in Hz, m is mass of the
substance in g/cm3, and χ0 is the mass susceptibility of the solvent in
Figure 1. Chemical structure of FeII-DOTAm-F12 (1).
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cm3/g. For D2O, the reported value −0.6466 × 10−6 cm3/g was used
for χ0. d0 and ds are the densities of the solvent and solution in g/cm
3,
respectively. The third term was not used in the calculation because it
is a negligible contribution to the overall magnetic moment.
The molar susceptibility (cm3/mol) was calculated by multiplying
the value of χg by the molecular weight of Fe
II-DOTAm-F12. The
diamagnetic contributions (χdia) from the sample were estimated from
Pascal’s constants. These values were then used in eq 2 to calculate the
paramagnetic magnetic susceptibility.
χ χ χ= +measured para dia (2)
The paramagnetic susceptibly value thus obtained from eq 2 was
then used to calculate the effective magnetic moment according to eq
3
χμ = T2.84 ( )eff M (3)
1H and 19F NMR Spectra. 1H NMR spectra of FeII-DOTAm-F12
were acquired on a Varian Inova VI-500 spectrometer at 500 MHz; 19F
NMR spectra were acquired on a Bruker Avance, AX-400 at 377 MHz.
All NMR spectra were acquired in D2O as the solvent and at room
temperature. KF (δ = −122.0 ppm) was used as an external standard
for 19F NMR. A delay time of 30 ms and acquisition time of 64 ms
were used for the collection of 1H and 19F NMR spectra of the FeII-
DOTAm-F12 complex. Variable temperature (room temperature to
130 °C) 1H NMR and 19F NMR spectra were recorded in DMSO on a
Bruker Avance III, AV-500, at 500 and 472 MHz, respectively.
T2-Weighted Images. MR images were acquired at 7.1 T on a
Bruker Avance 300 spectrometer equipped with a microimaging probe
at 21 °C. T2-weighted images were acquired by using a standard T2-
weighted RARE sequence with the following parameters: TR = 5 s, TE
= 3.2 ms, isotropic 128 × 128 acquisition matrix with a FOV (field of
view) of 10 mm and a slice thickness of 1 mm (matrix resolution of
0.078 mm/pixel). FOV = 10 mm × 10 mm, slice thickness = 1 mm,
RF = 32.
19F MR Images. 19F magnetic resonance images of water solutions
of FeII-DOTAm-F12 at variable pH and variable concentrations were
acquired at 7.1 T on a Bruker Avance 300 spectrometer. 19F images
were acquired at resonant frequencies of compounds by using a
FLASH sequence with the following parameters: TE = 3.08 ms, FOV =
33 mm × 33 mm, matrix = 32 × 32, slice thickness = 5 mm, flip angle
= 30°. TR was varied from 100 to 400 ms, and NS was varied from 64
to 512. Signal-to-noise ratios were calculated by taking the ratio of the
mean intensity in the circular region of interest (ROI) containing
whole sample over the mean intensity in an identically sized noise
region of the image. 19F MRI images have been processed by applying
a quadratic smoothing algorithm.
Z-Spectra and CEST MR Images. All the CEST MR images were
acquired at 7.1 T on a Bruker Advance 300 spectrometer equipped
with a microimaging probe at 21 °C. CEST MR images in water were
acquired with phantoms consisting of one empty glass capillary as
control and seven with aqueous solution of FeII-DOTAm-F12 at 10
mM concentration with pH ranging from 4 to 8. Four other aqueous
solutions at pH 7.4 but with varying concentration of FeII-DOTAm-
F12 were also analyzed. MR CEST phantom images of solutions in
buffer (PBS 1 mM phosphates) and serum were acquired with one
empty glass capillary as control along with capillaries containing 10
mM FeII-DOTAm-F12 at pH 6.9 and 7.4 in either buffer or human
serum. A standard RARE (rapid acquisition with refocused echoes)
spin−echo sequence (RF = 16) with an echo time of 3.2 ms and a TR
value of 5 s was used (four averages). An isotropic 64 × 64 acquisition
matrix with an FOV of 10 mm and a slice thickness of 1 mm were used
(matrix resolution of 0.156 mm/pixel). The entire sequence was
preceded by a saturation scheme consisting of a continuous
rectangular wave pulse 2 s long with variable radio frequency B1
intensity (12, 18, 24, 30, 36, or 42 μT). A frequency offset range of
±150 ppm was investigated. Image processing was carried out using
custom-made software, compiled in the Matlab platform (Mathworks
Inc., Natick, MA). The Z-spectra were interpolated by smoothing
splines to identify the zero-offset on a pixel-by-pixel basis of the bulk
water and to assess the correct ST% value over the entire range of
frequency offsets investigated.49 The CEST effect was calculated
according to eq 4, where MS is the intensity of the bulk water NMR
signal after the irradiation on resonance (Δω) of the mobile proton















Figure 2.Molecular structure of (a) the major isomer (67%) and (b) the minor isomer (33%) of FeII-DOTAm-F12 (ORTEP, 45% probability level).
Hydrogen atoms omitted for clarity.
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Determination of Proton Exchange Rate. The exchange rate
constant (kex = 1/τM) of the NH protons was measured by the Omega
plot method as reported by A. D. Sherry.50 In the Omega plots, [Mz/
(M0 − Mz)] is plotted versus 1/ω12, where ω1 is expressed in radians/
second. The bulk water signal intensity measurements were carried out
at the steady state after application of presaturation pulses at different
B1 values. The presaturation was carried out by using a 2 s long
rectangular pulse with B1 = 12, 18, 24, 30, and 36 μT. The τM value is
obtained by τ = −M x0 , where x0 is the x-axis intercept. Each linear
plot contains 5 points, with an R2 ≥ 0.97 (Figure S10).
Measurements of pH by CEST and 19F MR Images. The pH
can be assessed from the analysis of CEST and 19F MR images simply
by dividing the ST% obtained in the CEST image by the signal-to-
noise ratio obtained in the 19F image (ST%/SNR19F). Comparing this
ratio to a calibration curve performed in the same media and magnetic
field strength yields the pH.
■ RESULTS AND DISCUSSION
Crystal X-ray Structure of FeII-DOTAm-F12. FeII-
DOTAm-F12 was synthesized as previously reported.41
Interestingly, the single crystal X-ray structure of FeII-
DOTAm-F12 (Figure 2) demonstrates that the iron(II)
complex adopts a rare octacoordinated geometry. (See Tables
S1, S4−S7 in SI for coordinates and select bond lengths and
angles.) Although rare, 8-coordinate iron complexes are not
unprecedented. Two other octacoordinated Fe(II) complexes
involving tetraazamacrocycles have been reported.35,51 At least
11 other FeN8 and 13 FeO8 crystal structures of 8-coordinate
iron have been reported.52,53 The geometry of the molecule can
be best described as slightly distorted square-antiprismatic with
an average rotation angle of −41.52° between the oxygen and
nitrogen planes. The crystal structure was determined at 123(2)
K and indicates disorder and the presence of two structures in
an approximate 0.67:0.33 ratio (Figure 2). The structure has a
2-fold molecular axis that is near a crystallographic 2-fold axis.
Note the difference observed in an Fe−N bond length of the
coordinating cyclen moiety. The Fe−N distances fall mainly
into two groups, a short group with the average Fe−N distance
of 2.33 Å and a long group with an average Fe−N distance of
2.43 Å (Table S1). A difference of about 0.19 Å in the height of
the Fe atom from the N4 plane of the cyclen moiety was also
observed.
The coordinating nitrogen atoms of the cyclen moiety
∠N1−N2−N3−N4 and ∠N1′−N2′−N3′−N4′ are planar with
a dihedral angle of 0.07° and 0.63°. The amide oxygen atoms
also make a regular plane around the central iron atom with a
dihedral angle of −0.30°. The 12-N4 ring of the cyclen moiety
exists in two conformations: the average torsion angle of 57.22°
gives it δδδδ configuration, whereas distortion provides the
λλλλ configuration with an average torsion angle of −54.72°.
For the major isomer (Figure 2a), the values of regular N−C−
C−O torsion angles suggest that two of the four pendent arms
have left-handed helicity (Λ) while the other two show right-
handed helicity (Δ). This is uncommon for related lanthanide-
based complexes that exhibit mainly one type of helicity for the
pendent arms.54,55 For the minor isomer (Figure 2b), the
analysis of the N−C−C−O torsion angle due to distortion
suggests a left-handed helicity (Λ) for the pendent amide arms
with an average value of −23.25°. The four Fe−O bonds range
from 2.18 to 2.41 Å, values that are similar to those observed
for related octahedral FeII structures.35,56,57 The 12 fluorine
atoms lie between 5.22 and 6.84 Å away from the FeII, distances
that are comparable to those observed for the TmIII analogue of
the same ligand (4.5−7.5 Å).41 A water molecule is positioned
axially on top of the FeII ion. However, unlike in the structure
of the related TmIII analogues,41 the distance between the
central iron atom and the oxygen of the water molecule, 3.78 Å,
is too long to consider the water molecule as coordinated.
Magnetic Measurements. The variable temperature
magnetic property of the bulk sample was studied by SQUID
magnetometry. The measurements were carried out in both
heating and cooling modes in the range 2−300 K (Figure S3).
The magnetization data was simulated using the julX program
for exchange coupled systems.58 The simulation was based on
the spin-Hamiltonian operator for mononuclear complexes
shown in eq 5. The best fit was obtained with spin S = 2, axial
zero-field splitting parameter D = 9, rhombicity E/D = 0, and g
= 1.99 including 9% of paramagnetic impurity with S = 0.5.
From this fitting, the effective magnetic moment (μeff) of Fe
II-
DOTAm-F12 at 298 K was determined to be 4.60 μB. This
value is close to that calculated for the spin only value (S = 2)
for high-spin FeII (4.90 μB), indicating that the complex is in a
high-spin state at room temperature. The value of the effective

























The effective magnetic moment of the FeII complex was
further studied by solution NMR spectrometry according to
Evans’ method.48 A μeff of ∼6.0 μB was determined by solution
NMR. Although the effective magnetic moment value
determined in solution is different than that determined in
the solid state, both measurements suggest a high-spin state for
the FeII-DOTAm-F12 complex. The origin of the discrepancy
between the magnetic moment determined in solution and the
solid state is not fully understood at this point but could
potentially be due to a change in the environmental condition
of the complex between solution and the solid state. Such
differences are not uncommon and have been observed
previously for other complexes as well.59−61
To probe further the behavior of FeII-DOTAm-F12 in
solution, variable temperature 1H and 19F NMR were recorded.
The 1H NMR spectra of the complex in DMSO shows a
decrease in hyperfine shift with increasing temperature (Figure
S8). In contrast, a smaller change in the chemical shifts of the
19F nuclei is observed with increasing temperature (Figure S9).
This process is reversible and confirmed that the FeII complex
is stable up to 130 °C.
19F and CEST-MRI. The 19F NMR spectrum of FeII-
DOTAm-F12 in water (Figure S2) indicates that all 19F nuclei
remain equivalent by NMR. This strongly suggests that, in
solution at room temperature, the pseudo-4-fold symmetry of
the iron complex is maintained and that the FeII ion remains 8-
coordinate. In addition, the presence of a single peak suggests
that only one isomer is present in solution, and that the four
CF3 arms rotate faster than the NMR time scale.
As predicted, 19F MR images of solutions of FeII-DOTAm-
F12 indicate that the signal-to-noise ratio (SNR) of the 19F
phantom increases linearly with the concentration of the iron
complex (Figure S7a,b). The limit of detection of the iron
complex by 19F MRI, which is the concentration needed to
achieve an SNR of 3, is 2 mM. Interestingly, the limit-of-
detection of the complex is similar by 19F and STweighted
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(CEST) MRI (vide inf ra), indicating that the contrast agent can
be visualized by either modality with the same sensitivity, an
important parameter for ratiometric MR imaging. Importantly,
the intensity of the 19F signal of the probe is independent of pH
(Figure 3a). Capillary tubes filled with the same concentration
of [FeII-DOTAm-F12] but at different pH still display the same
signal intensity in a 19F MR image (Figure 5, tubes 1−4).
Although not surprising, this independence of the 19F MR
image on pH is crucial to the ability of the complex to behave
as its own internal standard. As can be seen in Figure 5, because
the 19F signal intensity is only dependent on the concentration
of FeII-DOTAm-F12 and not on the pH, the 19F MR image can
accurately map the concentration of the contrast agent
throughout a sample or tissue.
The NH groups of the arms are also chemically equivalent
and are close to the paramagnetic FeII center. As a result, the
1H NMR signal of the exchangeable protons is well-shifted 39
ppm away from the bulk water signal. Since the amide protons
exchange with bulk water protons in a pH-dependent manner,
FeII-DOTAm-F12 was anticipated to behave as a pH-responsive
CEST agent. The magnitude of saturation transfer indeed
increases substantially from ∼8% at pH 4 to a maximum 40% at
pH 6.2 (in aqueous solution). Interestingly, further increasing
the pH to 8 results in a substantial decrease of the CEST effect
to ∼25% ST. Notably, the decrease in ST% from pH 6.0 to 8.0
is opposite to the trend normally observed with paraCEST
agents.30,62,63 Generally, the saturation transfer increases as the
pH increases to 8 due to a base catalyzed increase of the proton
exchange rate.39,40 However, the exchange rates of amide
protons are well-known to depend on the electronic properties
of the appended amide group as well as pH. The presence of
CF3, an electron withdrawing substituent, in close proximity of
the amide enhances the acidity of its proton by pulling the
electron density away from the nitrogens. This facilitates
deprotonation of the amide and the development of negative
charge on the nitrogen that needs to be stabilized in order to
observe the CEST effect. It was previously shown that neutral
electronegative substituents tend to stabilize this charge thereby
shifting the maxima of saturation transfer toward lower pH
value.64 Negatively charged electron withdrawing groups,
however, have the opposite effect since they destabilize the
charged species.65 Moreover, coordination of the amide oxygen
to the central metal ion involves sharing the amide nitrogen’s
lone pair. This sharing also increases the acidity of the amide
proton and ultimately affects their pH sensitivity range.
In FeII-DOTAm-F12, since these two opposite factors are
both present, a maximum in the saturation transfer is observed
at slightly acidic pH (Figures 3b and 5, and Figure S6). This
distinguishes the fluorinated iron complex from most
paraCEST agents for which the maxima of saturation transfer
are observed in the basic pH range.39,40 The decrease in the
CEST intensity at a higher pH value is ascribable to the
increase in the exchange rate of the amide proton (kex). Faster
exchange rates increase saturation transfer, but only to a point
beyond which a too fast exchange rate causes NMR peaks to
coalesce which in turn decreases ST%. Notably, the presence of
a maximum in the ST% response is not detrimental to
biomedical applications. The pH of extracellular space where
MRI contrast agents that are administered intravenously can
accumulate is rarely lower than pH 6. pH mapping is
particularly relevant to diagnosis and monitoring of cancer. In
cancer tissues, the extracellular pH rarely decreases by more
than 1 pH unit. The extracellular pH of normal tissue is usually
pH 7.4; on the other extreme, under chronic acidosis it
Figure 3. (a) Signal-to-noise ratio in 19F MR image of a phantom made by glass capillaries containing 10 mM FeII-DOTAm-F12 complex in water as
a function of pH. (b) ST% vs pH from STweighted images upon irradiation at 39 ppm of phantom described in part a.
Figure 4. (a) ST-spectra and (b) STweighted images upon irradiation at 39 ppm of Fe
II-DOTAm-F12 in (1) phosphate buffered saline (PBS) at pH
6.9, (2) PBS at pH 7.4, (3) human serum at pH = 6.9, (4) human serum at pH 7.4, and (5) empty capillary tube. Experimental conditions: [FeII-
DOTAm-F12] = 10 mM, B1 = 30 μT.
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decreases to no less than 6.7.3,4 Importantly, ST% changes
linearly in pH range 6−7.5, which is the pH range of
physiological concern to cancer imaging.
The amide proton residence time (τm = 1/kex) of Fe
II-
DOTAm-F12 has been measured in phosphate buffered saline
(PBS) and human serum at 21 °C according to the Omega plot
method reported by A. D. Sherry et al. (Figure S10 and Table
S2).50 In both media, τm decreases substantially as the pH
increases from 6.9 to 7.4, although a much bigger decrease is
observed in serum (58%) than in PBS (24%). This substantial
change in τm and in the corresponding ST% strongly suggests
that the FeII complex could accurately map out small
differences in pH, such as those occurring in the extracellular
environments of tumors. In view of these possible in vivo
applications, Z-spectra, ST% spectra, and STweighted images of
solutions of FeII-DOTAm-F12 in PBS and human serum at
both pH 7.4 and 6.9, the pH of normal and hypoxic
extracellular environments, respectively, were obtained (Figure
4a,b). As expected, the increase in kex from pH 6.9 to 7.4, which
also broadens the NMR peak of the amide proton at higher pH
values (Figure S6), results in a significant increase in the CEST
effect. Images at pH 7.4 appear noticeably brighter than those
at pH 6.9 (Figure 4b). Note that the magnitude of the CEST
effect is also affected by other constituents of serum, as a ca.
10% decrease in CEST intensity is observed between serum
and buffer. The additional peak shifted 2−3 ppm away from
water that is present in serum but not PBS which is due to the
endogenous proteins of serum.66
As for all CEST contrast agents, the intensity of the MR
signal is a function of the concentration of the agents. For FeII-
DOTAm-F12, a direct relationship is observed by NMR
between the concentration of the iron complex and the
intensity of the CEST peak (Figure S5). Analysis of STweighted
phantoms, however, indicates that the increase in ST% and
signal intensity reaches a plateau above 4 mM (Figure S7c,d).
The limit of detection of FeII-DOTAm-F12 by CEST, defined
as the concentration of the iron complex needed to achieve a
ST% of 5%, is ca. 2 mM at pH 7.4. The saturation transfer of
FeII-DOTAm-F12 indicates that its sensitivity is in the same
order of magnitude as that of other previously reported FeII-
based paraCEST agents at both pH 6.9 and 7.4 (Table
S3).29,30,33,39,40 The chemical shift of the exchangeable proton
pool is far from the bulk water signal (Δω = 39 ppm), but not
completely outside the region in which the magnetization
transfer effect (MTC) of water bound to solid tissue is
present.67 The MTC effect depends strongly on the B1 field
used with a broader MTC signal obtained at higher B1. At the
B1 fields used in this work, the MTC effect extends to ca. 100
ppm from bulk water. Therefore, it is anticipated that FeII-
DOTAm-F12 will be less sensitive in tissue than in water.68
Moreover, an expected rise in the saturation transfer has
been observed upon increasing the irradiation power of the
presaturation pulse (Figure S4). Note, however, that practically,
for in vivo applications, high B1 values have to be avoided since
more intense presaturation pulses lead to higher specific
absorption rate (SAR) of energy in the imaged tissue, which is
detrimental to the patient’s health.
Notably, the signal intensity observed in the 19F MR image is
a function only of the concentration of the probe and is
independent of pH (Figure 5, left). On the other hand, the
signal intensity observed in STweighted CEST images is a function
both of the concentration of the probe and of the pH (Figure 5,
right). This different response toward pH in the two modalities
(19F and CEST MRI) advantageously enables rapid determi-
nation of the pH ratiometrically even under conditions where
the concentration of the probe is unknown. The spatial
distribution of the probe can be directly assessed by the 19F MR
image. The pH can then be assessed from the analysis of the
CEST and 19F MR images simply by dividing the ST% obtained
in the CEST image by the signal-to-noise ratio obtained in the
19F image. Comparing this ratio to a calibration curve
performed in the same media, temperature, and magnetic
field strength yields the pH.
■ CONCLUSION
FeII-DOTAm-F12 behaves as an MRI contrast with dual 19F
and CEST modality. The sensitivity of the complex is the same
in both modalities, with a limit of detection at ca. 2 mM. The
magnitude of the CEST response is dependent both on the
concentration of the complex and on the pH, with a maximum
of saturation transfer at pH 6.0 in water. On the other hand, the
SNR of the 19F signal is only dependent on the concentration
of the complex and is independent of pH. This difference in
response in the two modalities enables the complex to map pH
changes ratiometrically. The distribution of the complex can be
determined directly by the 19F MR images, which in turn
enables accurate determination of pH changes via STweighted
images. The substantial change in ST% enables accurate pH
mapping within a narrow pH range representative of hypoxic
tissues. Interestingly, FeII-DOTAm-F12 exists as a rare 8-
coordinate complex. The high-spin Fe(II) complex is stable in
air at room temperature for long periods of time (year).
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Figure 5. 19F (left) and CEST STweighted (right) phantom images of
FeII-DOTAm-F12 in water at variable pH and/or probe concentration:
(1) [FeII-DOTAm-F12] = 10 mM, pH 5.0; (2) [FeII-DOTAm-F12] =
10 mM, pH 5.5; (3) [FeII-DOTAm-F12] = 10 mM, pH 6.2; (4) [FeII-
DOTAm-F12] = 10 mM, pH 7.0; (5) [FeII-DOTAm-F12] = 6 mM,
pH 7.0; (6) [FeII-DOTAm-F12] = 4 mM, pH 7.0; (7) [FeII-DOTAm-
F12] = 2 mM, pH 7.0. Note that the signal intensity observed in the
19F phantom is dependent on the concentration of the probe (tubes 1,
5, 6, and 7) but is independent of the pH (tubes 1−4), thereby
enabling determination of the spatial distribution of the probe
independently of the pH. The pH can then be determined from the
intensity of the CEST image.
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